Announce Date | 07/01/2025 |
EPS Normalized Actual | $1.86 (Beat by $1) |
EPS GAAP Actual | $1.86 (Beat by $1) |
Revenue Actual | $0.8427B |
Revenue Surprise | Beat by $842.7M |
Announce Date | 08/28/2025 (Pre-Market) |
EPS Normalized Estimate | $1.19333 |
EPS GAAP Estimate | $1.19333 |
Revenue Estimate | $0.93985B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2026 | 4.58 | 10.83 | 4.55183 | 4.61333 | 1 |
Aug 2025 | 3.55 | 13.97 | 3.25 | 3.75 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 1.92 | 0.75 | 0.8427B | 2.85% | -89.63M |
FQ1 2025 (Feb 2025) | 1.66 | 1.66 | 0.7621B | -12.98% | 762.1M |
FQ4 2024 (Nov 2024) | 3.9 | 3.9 | 0B | -INF% | 0M |
FQ3 2024 (Aug 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ2 2024 (May 2024) | 1.09 | 1.09 | 0.8187B | 100% | 818.7M |
FQ1 2024 (Feb 2024) | 1.07 | 1.07 | 0.861B | 100% | 861M |
FQ4 2023 (Nov 2023) | 1 | 1 | 0.8088B | 100% | 808.8M |
FQ3 2023 (Aug 2023) | 0.76 | 0.76 | 1.0174B | 100% | 1017.4M |
FQ4 Announce Date
08/28/2025 (Pre-Market)
Consensus EPS Estimates
1.19333
Consensus Revenue Estimates
0.93985B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Aug 2026) | 1.3 | -- | 1.28121 | 1.32167 | 2 |
FQ2 2026 (May 2026) | 1.3 | -47.69 | 1.28121 | 1.32167 | 2 |
FQ1 2026 (Feb 2026) | 1.07 | -55.14 | 1.04915 | 1.09085 | 1 |
FQ4 2025 (Nov 2025) | 1.15 | -239.13 | 1.15 | 1.15 | 1 |
FQ3 2025 (Aug 2025) | 1.19333 | -- | 1.17608 | 1.21323 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Aug 2026) | 0.98B | -- | 0.97B | 0.99B | 1 |
FQ2 2026 (May 2026) | 0.98B | 14.3 | 0.97B | 1B | 1 |
FQ1 2026 (Feb 2026) | 0.88B | 13.14 | 0.86B | 0.89B | 1 |
FQ4 2025 (Nov 2025) | 0.81B | -- | 0.81B | 0.81B | 1 |
FQ3 2025 (Aug 2025) | 0.94B | -- | 0.93B | 0.95B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
1
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 1.17 | 1.92 | 0.75 | 39.06% |
FQ1 2025 (Feb 2025) | 1.66 | 1.66 | 100% | |
FQ4 2024 (Nov 2024) | 3.9 | 3.9 | 100% | |
FQ3 2024 (Aug 2024) | 0 | 0 | NAN% | |
FQ2 2024 (May 2024) | 1.09 | 1.09 | 100% | |
FQ1 2024 (Feb 2024) | 1.07 | 1.07 | 100% | |
FQ4 2023 (Nov 2023) | 1 | 1 | 100% | |
FQ3 2023 (Aug 2023) | 0.76 | 0.76 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0.93B | $0.84B | $-89.63M | -10.64% |
FQ1 2025 (Feb 2025) | $0B | $0.76B | $762.1M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Aug 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (May 2024) | $0B | $0.82B | $818.7M | 100% |
FQ1 2024 (Feb 2024) | $0B | $0.86B | $861M | 100% |
FQ4 2023 (Nov 2023) | $0B | $0.81B | $808.8M | 100% |
FQ3 2023 (Aug 2023) | $0B | $1.02B | $1017.4M | 100% |